We’re tracking in-house compensation. Take the Law360 Survey
Click here
Masih v. Perrigo Company PLC et al
-
April 01, 2021
Perrigo misrepresented a major tax liability and harmed investors by failing to properly disclose a nearly €1.6 billion ($1.9 billion) tax liability, two Florida public service pension funds said in seeking an early win in a class action.
-
February 10, 2021
A Manhattan federal court said Wednesday that investors in a class action accusing drugmaker Perrigo of hiding a €1.6 billion ($1.9 billion) tax bill can't amend their original complaint to revive dismissed claims surrounding a 2018 regulatory filing.
-
December 09, 2020
A New York federal judge ruled Tuesday that Perrigo must fork over legal advice the drugmaker received related to its choice to not disclose to U.S. investors a $1.9 billion Irish tax bill, finding the advice isn't shielded by attorney-client privilege.
-
September 25, 2020
A federal judge certified a class action in a suit accusing drugmaker Perrigo of concealing a €1.6 billion ($1.9 billion) tax bill from investors, ruling that a pair of Florida-based pension funds can adequately represent their members as lead plaintiffs.
-
August 17, 2020
Two Florida pension funds are unqualified to lead a class action against Irish drugmaker Perrigo because they aren't taking an active role in the litigation, company attorneys told a New York federal court.
-
July 17, 2020
Investors suing drugmaker Perrigo for allegedly hiding a nearly $2 billion tax bill were rebuffed Thursday by a New York federal judge, who denied their request to ask Ireland's Office of the Revenue Commissioners for evidence in the case.
-
July 13, 2020
Two Florida public service pension funds are qualified to lead an investor class action accusing drugmaker Perrigo of harming investors by waiting to tell them about a nearly $2 billion tax charge, the funds' attorneys told a federal court.
-
January 23, 2020
A federal judge in New York on Thursday trimmed allegations from a shareholders' action alleging that Irish drug company Perrigo and some of its top executives did not tell investors soon enough about a tax audit in the Emerald Isle.
-
May 06, 2019
Drugmaker Perrigo is pushing back on a securities fraud suit over Irish tax officials' audit of a 2013 intellectual property sale, saying it has been forthcoming with investors about the audit every step of the way.
-
January 04, 2019
Irish drug company Perrigo defrauded investors by concealing a tax liability so large that its stock fell almost 30 percent the day it was revealed, a Maryland shareholder claimed in a proposed class action filed Thursday in New York federal court.